Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2

Aengus S. O'Marcaigh, Christopher M. Johnson, William A. Smithson, M. C. Patterson, Brigitte C. Widemann, Peter C. Adamson, Michael J. Mcmanus

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Prompt and appropriate management measures are critical in order to achieve a favorable outcome after a major overdose of intrathecally (IT) administered methotrexate (MTX). Published information available to guide clinicians in the immediate management of this medical emergency is scant. Herein we describe a 6-year-old boy with acute lymphoblastic leukemia who received an inadvertent overdose of 600 mg of IT administered MTX instead of the intended dose of 12 mg. Severe acute neurotoxicity developed rapidly. Lumbar puncture and drainage of 15 mL of cerebrospinal fluid 2 hours after administration resulted in removal of 32% of the administered drug. Ventriculolumbar perfusion with 240 mL of warmed isotonic saline through ventricular and lumbar catheters for 3 hours resulted in removal of a total of 90% of the drug within 8 1/2 hours after administration. IT administration of 2,000 U of carboxypeptidase G2 (CPDG2), an enzyme that inactivates MTX, resulted in a further 150-fold reduction in cerebrospinal fluid MTX concentration. The patient experienced complete recovery. To our knowledge, this is the first reported case of the use of IT instillation of CPDG2 for the treatment of an overdose of IT administered MTX in a human, and it is only the second reported favorable outcome after an IT overdose of more than 500 mg of MTX. Minor IT overdoses of MTX can be managed by immediate lumbar drainage alone. Major overdoses may also necessitate prompt ventriculolumbar perfusion, IT instillation of CPDG2, and further supportive measures for a successful outcome after this infrequent but potentially catastrophic event.

Original languageEnglish (US)
Pages (from-to)161-165
Number of pages5
JournalMayo Clinic Proceedings
Volume71
Issue number2
StatePublished - 1996
Externally publishedYes

Fingerprint

gamma-Glutamyl Hydrolase
Methotrexate
Perfusion
Therapeutics
Cerebrospinal Fluid
Paracentesis
Spinal Puncture
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Pharmaceutical Preparations
Drainage
Emergencies
Catheters

ASJC Scopus subject areas

  • Medicine(all)

Cite this

O'Marcaigh, A. S., Johnson, C. M., Smithson, W. A., Patterson, M. C., Widemann, B. C., Adamson, P. C., & Mcmanus, M. J. (1996). Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2. Mayo Clinic Proceedings, 71(2), 161-165.

Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2. / O'Marcaigh, Aengus S.; Johnson, Christopher M.; Smithson, William A.; Patterson, M. C.; Widemann, Brigitte C.; Adamson, Peter C.; Mcmanus, Michael J.

In: Mayo Clinic Proceedings, Vol. 71, No. 2, 1996, p. 161-165.

Research output: Contribution to journalArticle

O'Marcaigh, AS, Johnson, CM, Smithson, WA, Patterson, MC, Widemann, BC, Adamson, PC & Mcmanus, MJ 1996, 'Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2', Mayo Clinic Proceedings, vol. 71, no. 2, pp. 161-165.
O'Marcaigh, Aengus S. ; Johnson, Christopher M. ; Smithson, William A. ; Patterson, M. C. ; Widemann, Brigitte C. ; Adamson, Peter C. ; Mcmanus, Michael J. / Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2. In: Mayo Clinic Proceedings. 1996 ; Vol. 71, No. 2. pp. 161-165.
@article{697d54a0978646c69b16778acf1da4e9,
title = "Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2",
abstract = "Prompt and appropriate management measures are critical in order to achieve a favorable outcome after a major overdose of intrathecally (IT) administered methotrexate (MTX). Published information available to guide clinicians in the immediate management of this medical emergency is scant. Herein we describe a 6-year-old boy with acute lymphoblastic leukemia who received an inadvertent overdose of 600 mg of IT administered MTX instead of the intended dose of 12 mg. Severe acute neurotoxicity developed rapidly. Lumbar puncture and drainage of 15 mL of cerebrospinal fluid 2 hours after administration resulted in removal of 32{\%} of the administered drug. Ventriculolumbar perfusion with 240 mL of warmed isotonic saline through ventricular and lumbar catheters for 3 hours resulted in removal of a total of 90{\%} of the drug within 8 1/2 hours after administration. IT administration of 2,000 U of carboxypeptidase G2 (CPDG2), an enzyme that inactivates MTX, resulted in a further 150-fold reduction in cerebrospinal fluid MTX concentration. The patient experienced complete recovery. To our knowledge, this is the first reported case of the use of IT instillation of CPDG2 for the treatment of an overdose of IT administered MTX in a human, and it is only the second reported favorable outcome after an IT overdose of more than 500 mg of MTX. Minor IT overdoses of MTX can be managed by immediate lumbar drainage alone. Major overdoses may also necessitate prompt ventriculolumbar perfusion, IT instillation of CPDG2, and further supportive measures for a successful outcome after this infrequent but potentially catastrophic event.",
author = "O'Marcaigh, {Aengus S.} and Johnson, {Christopher M.} and Smithson, {William A.} and Patterson, {M. C.} and Widemann, {Brigitte C.} and Adamson, {Peter C.} and Mcmanus, {Michael J.}",
year = "1996",
language = "English (US)",
volume = "71",
pages = "161--165",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "2",

}

TY - JOUR

T1 - Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2

AU - O'Marcaigh, Aengus S.

AU - Johnson, Christopher M.

AU - Smithson, William A.

AU - Patterson, M. C.

AU - Widemann, Brigitte C.

AU - Adamson, Peter C.

AU - Mcmanus, Michael J.

PY - 1996

Y1 - 1996

N2 - Prompt and appropriate management measures are critical in order to achieve a favorable outcome after a major overdose of intrathecally (IT) administered methotrexate (MTX). Published information available to guide clinicians in the immediate management of this medical emergency is scant. Herein we describe a 6-year-old boy with acute lymphoblastic leukemia who received an inadvertent overdose of 600 mg of IT administered MTX instead of the intended dose of 12 mg. Severe acute neurotoxicity developed rapidly. Lumbar puncture and drainage of 15 mL of cerebrospinal fluid 2 hours after administration resulted in removal of 32% of the administered drug. Ventriculolumbar perfusion with 240 mL of warmed isotonic saline through ventricular and lumbar catheters for 3 hours resulted in removal of a total of 90% of the drug within 8 1/2 hours after administration. IT administration of 2,000 U of carboxypeptidase G2 (CPDG2), an enzyme that inactivates MTX, resulted in a further 150-fold reduction in cerebrospinal fluid MTX concentration. The patient experienced complete recovery. To our knowledge, this is the first reported case of the use of IT instillation of CPDG2 for the treatment of an overdose of IT administered MTX in a human, and it is only the second reported favorable outcome after an IT overdose of more than 500 mg of MTX. Minor IT overdoses of MTX can be managed by immediate lumbar drainage alone. Major overdoses may also necessitate prompt ventriculolumbar perfusion, IT instillation of CPDG2, and further supportive measures for a successful outcome after this infrequent but potentially catastrophic event.

AB - Prompt and appropriate management measures are critical in order to achieve a favorable outcome after a major overdose of intrathecally (IT) administered methotrexate (MTX). Published information available to guide clinicians in the immediate management of this medical emergency is scant. Herein we describe a 6-year-old boy with acute lymphoblastic leukemia who received an inadvertent overdose of 600 mg of IT administered MTX instead of the intended dose of 12 mg. Severe acute neurotoxicity developed rapidly. Lumbar puncture and drainage of 15 mL of cerebrospinal fluid 2 hours after administration resulted in removal of 32% of the administered drug. Ventriculolumbar perfusion with 240 mL of warmed isotonic saline through ventricular and lumbar catheters for 3 hours resulted in removal of a total of 90% of the drug within 8 1/2 hours after administration. IT administration of 2,000 U of carboxypeptidase G2 (CPDG2), an enzyme that inactivates MTX, resulted in a further 150-fold reduction in cerebrospinal fluid MTX concentration. The patient experienced complete recovery. To our knowledge, this is the first reported case of the use of IT instillation of CPDG2 for the treatment of an overdose of IT administered MTX in a human, and it is only the second reported favorable outcome after an IT overdose of more than 500 mg of MTX. Minor IT overdoses of MTX can be managed by immediate lumbar drainage alone. Major overdoses may also necessitate prompt ventriculolumbar perfusion, IT instillation of CPDG2, and further supportive measures for a successful outcome after this infrequent but potentially catastrophic event.

UR - http://www.scopus.com/inward/record.url?scp=0030060048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030060048&partnerID=8YFLogxK

M3 - Article

C2 - 8577190

AN - SCOPUS:0030060048

VL - 71

SP - 161

EP - 165

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 2

ER -